Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.
scientific article published on 15 July 2013
Author/s
author: Liliana Devizzi, Simonetta Viviani, Anna Guidetti, Ettore Seregni, Roberto Passera, Marco Maccauro, Maria Adele Testi, Massimo Di Nicola, Paola Matteucci, Marco Ruella, Carmelo Carlo-Stella, Carlo Chiesa, M Christina Cox, Emilio Bombardieri, Corrado Tarella
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.